Belgium· BE-AMP-SAM088846-00
Bilefal
A medicinal product containing cynara scolymus, extract, powder, registered in Belgium by Fall.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cynara Scolymus, Extract, Powder
- Manufacturer
- Fall
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0132779
- be_apb0665414
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7ccc569-072e-4d13-92ae-d843027d3c7d GET /v1/drugs/f7ccc569-072e-4d13-92ae-d843027d3c7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Herbal tea",
"source": "afmps",
"status": "REVOKED",
"name_en": "Bilefal",
"name_fr": "Bilefal",
"name_nl": "Bilefal",
"amp_code": "SAM088846-00",
"strengths": [
"200.0000",
"100.0000",
"100.0000",
"100.0000",
"200.0000",
"100.0000",
"100.0000"
],
"pack_count": 2,
"substances": [
"Cynara Scolymus, Extract, Powder",
"Frangula, Cortex, Extract",
"Rhubarb",
"Rosmarinus, Leaf, Tincture",
"Boldo",
"Calendulae Officinalis, Flower",
"Achillea Millefolium L., Herb"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"0606S 0017F010"
]
}See everything about cynara scolymus, extract, powder.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.